Study guide
Posterior inflammatory patterns and immunomodulation
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Posterior inflammatory patterns and immunomodulation
Key Takeaways Explain This Topic AI
HLA-A29 supports a compatible birdshot phenotype but does not diagnose disease by itself.
White-dot syndromes differ in prognosis, neurological associations and need for treatment.
Bilateral panuveitis after penetration or surgery raises concern for sympathetic ophthalmia.
Immunomodulation requires agent-specific infection screening, laboratory monitoring and reproductive counselling.
Last updated: October 2026
Separate morphology from a final cause
Posterior inflammatory disease can involve retina, choroid, retinal vessels or several tissues. White-dot syndromes describe recognizable patterns rather than one interchangeable condition. Birdshot chorioretinitis, multiple evanescent white-dot syndrome, placoid disease and multifocal choroiditis have different courses and treatment needs. Infection and masquerade disease must remain in the differential before systemic immunosuppression.
Assess symptoms, laterality, course, vitreous cells, vascular leakage, macular fluid and lesion depth. Use optical coherence tomography, fluorescein or indocyanine green angiography and autofluorescence to answer specific questions. Visual acuity alone can underestimate impairment: night vision, contrast, fields and electrophysiology may disclose substantial dysfunction despite a relatively good letter score.
Birdshot and white-dot patterns
Birdshot chorioretinitis typically produces bilateral cream-coloured choroidal lesions with vitreous inflammation and retinal vascular involvement. HLA-A29 is strongly associated and can support a compatible diagnosis, but a positive HLA result in a healthy person is not birdshot. Indocyanine green imaging can reveal choroidal involvement when visible spots are subtle. Macular oedema, vasculitis and functional loss guide treatment and monitoring.
Multiple evanescent white-dot syndrome (MEWDS) commonly presents with unilateral photopsias, blind-spot enlargement and small transient outer-retinal lesions. Many uncomplicated cases recover without systemic immunosuppression. Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) produces larger placoid lesions and may have neurological associations; headache or neurological symptoms require attention rather than dismissal as an incidental viral illness.
Multifocal choroiditis and punctate inner choroidopathy can produce punched-out lesions and secondary choroidal neovascularization. The degree of vitreous inflammation and typical patient profile help distinguish patterns. Treating an active CNV and controlling active inflammation are related but different tasks. Serpiginous-pattern disease requires consideration of tuberculosis-associated and other infectious mimics before immunosuppression.
- Pattern Important distinction Monitoring priority
- Birdshot Compatible phenotype plus HLA association Vascular leakage, oedema and function
- MEWDS Often transient unilateral outer-retinal disease Recovery and atypical progression
- Placoid disease Potential systemic or neurological association Ocular and neurological symptoms
Multifocal or serpiginous lesions Infectious mimics and CNV Lesion activity, infection and vascular complications
Sympathetic ophthalmia
Sympathetic ophthalmia is bilateral granulomatous panuveitis after penetrating ocular injury or intraocular surgery. The previously injured eye is the exciting eye and the fellow eye the sympathizing eye. Serous detachments and choroidal thickening may occur. The history helps distinguish it from Vogt–Koyanagi–Harada disease, although both can show diffuse choroidal inflammation.
Urgent specialist treatment aims to suppress inflammation and protect both eyes, often using systemic corticosteroids and steroid-sparing agents. Do not teach that removing an eye by a fixed day count guarantees prevention, or that an eye with useful vision must be sacrificed after the diagnosis. Eye-removal decisions involve visual potential, pain, structural injury and an informed discussion; established bilateral inflammation still requires medical treatment.
Steroid-sparing strategy
Repeated systemic steroids can cause major cumulative toxicity. Consider immunomodulation when inflammation is recurrent, sight-threatening, dependent on substantial corticosteroid exposure or unsuitable for local treatment alone. Conventional agents include methotrexate, mycophenolate, azathioprine and calcineurin inhibitors; selected biologics include adalimumab. The choice follows phenotype, comorbidity, reproductive plans and previous response, with specialist supervision.
Before treatment, assess infection risk, vaccination status and relevant laboratory baselines. TB and hepatitis screening matter for selected biologic pathways. Monitor blood count, liver or renal function as required by the chosen agent, rather than giving every drug the same monitoring schedule. Methotrexate's weekly regimen is a critical safety point: confusing it with daily administration can be catastrophic. Calcineurin inhibitors require attention to blood pressure, renal function and interactions.
Intravitreal or periocular steroids can help selected unilateral or asymmetric inflammation and oedema, but cause cataract, pressure elevation and infection risk. A local implant does not treat every systemic manifestation or remove the need to monitor the fellow eye. Reassess nonresponse for infection, irreversible structural damage, poor adherence or an incorrect diagnosis rather than merely increasing immunosuppression.
Clinical application
A patient with bilateral birdshot lesions, vascular leakage and worsening fields needs activity assessment beyond acuity. A unilateral transient white-dot presentation may need monitoring rather than the same biologic regimen. A patient with bilateral choroidal inflammation following ocular penetration requires urgent consideration of sympathetic ophthalmia. State the evidence for inflammation, the important excluded infection and how the proposed therapy will be monitored.
Sources: SUN birdshot classification study and EMA adalimumab information .
Case: activity despite a quiet anterior chamber
A patient with posterior inflammatory disease has few anterior chamber cells but new retinal vascular leakage and declining function. The quiet anterior chamber does not prove that the posterior disease is controlled. Compare imaging with previous studies, identify infection or a masquerade when the pattern is atypical, and document the specific active lesions. A scar and an active lesion have different implications. If systemic immunomodulation is planned, coordinate infection screening, laboratory monitoring and pregnancy considerations for the selected drug; these requirements vary between agents. Treatment success includes preserved vision and suppression of the relevant posterior activity, while steroid toxicity may still require a change despite apparent inflammatory control. In the clinical station, state what observation establishes activity, what alternative diagnosis needs exclusion and how follow-up will measure response. Avoid choosing a biologic solely from the disease name without the systemic and safety context.
Sections you finish are checked off in the contents.
- Up Next
- Toxoplasmosis and herpetic necrotizing retinitis
- Chapter 34: Infectious Uveitis and Endophthalmitis